The ERA-NET TRANSCAN-2 project successfully closed on June 30th, 2021
The action is continuing with the ERA-NET TRANSCAN-3: Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264).
TRANSCAN-3 JOINT TRANSNATIONAL CALL 2022
on the topic:
"Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"
is open for submission
Please visit the TRANSCAN-3 website at
https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl
and follow us on: 
Some of the TRANSCAN-2 funded projects are still ongoing and the individual project webpages will be continuously updated.
ERA-NET TRANSCAN-2
The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.
It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.
TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.
Coordination:
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi
Contact:
Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.
